Conducting clinical trials during the COVID-19 pandemic—a collaborative trial network response
Abstract The unprecedented demand placed on healthcare systems from the COVID-19 pandemic has forced a reassessment of clinical trial conduct and feasibility. Consequently, the Australasian Kidney Trials Network (AKTN), an established collaborative research group known for conducting investigator-initiated global clinical trials, had to efficiently respond and adapt to the changing landscape during COVID-19. Key priorities included ensuring patient and staff safety, trial integrity and network sustainability for the kidney care community. New resources have been developed to enable a structured review and contingency plan of trial activities during the pandemic and beyond..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:22 |
|---|---|
| Enthalten in: |
Trials - 22(2021), 1, Seite 9 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Laura Robison [VerfasserIn] |
|---|
| Links: |
doi.org [kostenfrei] |
|---|
| Themen: |
|---|
| doi: |
10.1186/s13063-021-05200-0 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
DOAJ062276956 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ062276956 | ||
| 003 | DE-627 | ||
| 005 | 20230503114253.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230228s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1186/s13063-021-05200-0 |2 doi | |
| 035 | |a (DE-627)DOAJ062276956 | ||
| 035 | |a (DE-599)DOAJ46c368d2f3dc4ad396f4ecb7a4d843c9 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 050 | 0 | |a R5-920 | |
| 100 | 0 | |a Laura Robison |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Conducting clinical trials during the COVID-19 pandemic—a collaborative trial network response |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Abstract The unprecedented demand placed on healthcare systems from the COVID-19 pandemic has forced a reassessment of clinical trial conduct and feasibility. Consequently, the Australasian Kidney Trials Network (AKTN), an established collaborative research group known for conducting investigator-initiated global clinical trials, had to efficiently respond and adapt to the changing landscape during COVID-19. Key priorities included ensuring patient and staff safety, trial integrity and network sustainability for the kidney care community. New resources have been developed to enable a structured review and contingency plan of trial activities during the pandemic and beyond. | ||
| 653 | 0 | |a Medicine (General) | |
| 700 | 0 | |a Yeoungjee Cho |e verfasserin |4 aut | |
| 700 | 0 | |a Andrea K. Viecelli |e verfasserin |4 aut | |
| 700 | 0 | |a David W. Johnson |e verfasserin |4 aut | |
| 700 | 0 | |a Carmel M. Hawley |e verfasserin |4 aut | |
| 700 | 0 | |a Andrea Valks |e verfasserin |4 aut | |
| 700 | 0 | |a Peta-Anne Paul-Brent |e verfasserin |4 aut | |
| 700 | 0 | |a Ruth Stastny |e verfasserin |4 aut | |
| 700 | 0 | |a Julie Varghese |e verfasserin |4 aut | |
| 700 | 0 | |a Charani Kiriwandeniya |e verfasserin |4 aut | |
| 700 | 0 | |a Elaine M. Pascoe |e verfasserin |4 aut | |
| 700 | 0 | |a Liza A. Vergara |e verfasserin |4 aut | |
| 700 | 0 | |a Magid A. Fahim |e verfasserin |4 aut | |
| 700 | 0 | |a Neil Boudville |e verfasserin |4 aut | |
| 700 | 0 | |a Rathika Krishnasamy |e verfasserin |4 aut | |
| 700 | 0 | |a Donna Reidlinger |e verfasserin |4 aut | |
| 700 | 0 | |a on behalf of the Australasian Kidney Trials Network |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t Trials |d BMC, 2006 |g 22(2021), 1, Seite 9 |w (DE-627)DOAJ000057452 |x 17456215 |7 nnns |
| 773 | 1 | 8 | |g volume:22 |g year:2021 |g number:1 |g pages:9 |
| 856 | 4 | 0 | |u https://doi.org/10.1186/s13063-021-05200-0 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/46c368d2f3dc4ad396f4ecb7a4d843c9 |z kostenfrei |
| 856 | 4 | 0 | |u https://doi.org/10.1186/s13063-021-05200-0 |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/1745-6215 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 912 | |a SSG-OLC-PHA | ||
| 951 | |a AR | ||
| 952 | |d 22 |j 2021 |e 1 |h 9 | ||